Cabinet okays THB3.6 billion for development of Thai vaccines
The Cabinet has approved a budget of THB2.3 billion for phase 3 clinical testing and production of the ChulaCov19 mRNA vaccine, deputy government spokesperson Ratchada Thanadirek said on Thursday.
In a meeting, the Cabinet also approved in principle a budget of not more than THB1.3 billion for research and development of the Baiya vaccine.
The main goal is to enable Thailand to produce a vaccine by itself so it can have at least 60 million doses on hand each year to provide immunity to Thais against Covid-19.
